Literature DB >> 25315124

Integrated analysis reveals that STAT3 is central to the crosstalk between HER/ErbB receptor signaling pathways in human mammary epithelial cells.

Chunhong Gong1, Yi Zhang, Harish Shankaran, Haluk Resat.   

Abstract

Human epidermal growth factor receptors (HER, also known as ErbB) drive cellular proliferation, pro-survival and stress responses by activating several downstream kinases, in particular ERK, p38 MAPK, JNK (SAPK), the PI3K/AKT, as well as various transcriptional regulators such as STAT3. When co-expressed, the first three members of HER family (HER1-3) can form homo- and hetero-dimers, and there is considerable evidence suggesting that the receptor dimers differentially activate intracellular signaling pathways. To better understand the interactions in this system, we pursued multi-factorial experiments where HER dimerization patterns and signaling pathways were rationally perturbed. We measured the activation of HER1-3 receptors and of the sentinel signaling proteins ERK, AKT, p38 MAPK, JNK, STAT3 as a function of time in a panel of human mammary epithelial (HME) cells expressing different levels of HER1-3 stimulated with various ligand combinations. We hypothesized that the HER dimerization pattern is a better predictor of downstream signaling than the total receptor activation levels. We validated this hypothesis using a combination of model-based analysis to quantify the HER dimerization patterns, and by clustering the activation data in multiple ways to confirm that the HER receptor dimer is a better predictor of the signaling through p38 MAPK, ERK and AKT pathways than the total HER receptor expression and activation levels. We then pursued combinatorial inhibition studies to identify the causal regulatory interactions between sentinel signaling proteins. Quantitative analysis of the collected data using the modular response analysis (MRA) and its Bayesian Variable Selection Algorithm (BVSA) version allowed us to obtain a consensus regulatory interaction model, which revealed that STAT3 occupies a central role in the crosstalk between the studied pathways in HME cells. Results of the BVSA/MRA and cluster analysis were in agreement with each other.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25315124      PMCID: PMC4540226          DOI: 10.1039/c4mb00471j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  95 in total

1.  Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.

Authors:  C J Wu; X Qian; D M O'Rourke
Journal:  DNA Cell Biol       Date:  1999-10       Impact factor: 3.311

2.  Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.

Authors:  O Danos; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 3.  Regulation of MAPKs by growth factors and receptor tyrosine kinases.

Authors:  Menachem Katz; Ido Amit; Yosef Yarden
Journal:  Biochim Biophys Acta       Date:  2007-01-10

Review 4.  ErbB-targeted therapeutic approaches in human cancer.

Authors:  Carlos L Arteaga
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

5.  Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.

Authors:  Caroline J Witton; Jonathan R Reeves; James J Going; Timothy G Cooke; John M S Bartlett
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

6.  Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product.

Authors:  H H Kim; S L Sierke; J G Koland
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

7.  ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface.

Authors:  Mitchell B Berger; Jeannine M Mendrola; Mark A Lemmon
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

Review 8.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

9.  Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway.

Authors:  Kazuko Sakai; Hideyuki Yokote; Kimiko Murakami-Murofushi; Tomohide Tamura; Nagahiro Saijo; Kazuto Nishio
Journal:  Cancer Sci       Date:  2007-07-11       Impact factor: 6.716

10.  Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses.

Authors:  Marc R Birtwistle; Mariko Hatakeyama; Noriko Yumoto; Babatunde A Ogunnaike; Jan B Hoek; Boris N Kholodenko
Journal:  Mol Syst Biol       Date:  2007-11-13       Impact factor: 11.429

View more
  8 in total

1.  Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma.

Authors:  Dominic Lapadula; Eduardo Farias; Clinita E Randolph; Timothy J Purwin; Dougan McGrath; Thomas H Charpentier; Lihong Zhang; Shihua Wu; Mizue Terai; Takami Sato; Gregory G Tall; Naiming Zhou; Philip B Wedegaertner; Andrew E Aplin; Julio Aguirre-Ghiso; Jeffrey L Benovic
Journal:  Mol Cancer Res       Date:  2018-12-19       Impact factor: 5.852

2.  In silico prediction of ErbB signal activation from receptor expression profiles through a data analytics pipeline.

Authors:  Arya A Das; Elizabeth Jacob
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

3.  EGFR signaling pathways are wired differently in normal 184A1L5 human mammary epithelial and MDA-MB-231 breast cancer cells.

Authors:  Zachary Speth; Tanzila Islam; Kasturi Banerjee; Haluk Resat
Journal:  J Cell Commun Signal       Date:  2017-03-29       Impact factor: 5.782

Review 4.  Constitutive activation of STAT3 in breast cancer cells: A review.

Authors:  Kasturi Banerjee; Haluk Resat
Journal:  Int J Cancer       Date:  2015-11-28       Impact factor: 7.396

Review 5.  Targeting cancer by binding iron: Dissecting cellular signaling pathways.

Authors:  Goldie Y L Lui; Zaklina Kovacevic; Vera Richardson; Angelica M Merlot; Danuta S Kalinowski; Des R Richardson
Journal:  Oncotarget       Date:  2015-08-07

6.  APC loss in breast cancer leads to doxorubicin resistance via STAT3 activation.

Authors:  Monica K VanKlompenberg; Emily Leyden; Anne H Arnason; Jian-Ting Zhang; Casey D Stefanski; Jenifer R Prosperi
Journal:  Oncotarget       Date:  2017-11-01

7.  Mapping connections in signaling networks with ambiguous modularity.

Authors:  Daniel Lill; Oleksii S Rukhlenko; Anthony James Mc Elwee; Eugene Kashdan; Jens Timmer; Boris N Kholodenko
Journal:  NPJ Syst Biol Appl       Date:  2019-05-23

8.  Impact of measurement noise, experimental design, and estimation methods on Modular Response Analysis based network reconstruction.

Authors:  Caterina Thomaseth; Dirk Fey; Tapesh Santra; Oleksii S Rukhlenko; Nicole E Radde; Boris N Kholodenko
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.